Longeveron Mesenchymal Stem Cells

· Longeveron Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Longeveron Mesenchymal Stem Cells, covering 2022-03-07 to 2022-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty [Phase 2]